Salvatore Pizzo

Q: What Schools Are Affiliated With Salvatore Pizzo

Salvatore Pizzo is affiliated with the following schools: McGill University, Stanford University, Johns Hopkins University, University of California, San Francisco, Columbia University, Duke University, Harvard University

Salvatore Pizzo's AcademicInfluence.com Rankings

Salvatore Pizzo

Philosophy

#4266

World Rank

#6729

Historical Rank

Logic

#1773

World Rank

#2612

Historical Rank

philosophy Degrees

Salvatore Pizzo

Biology

#5562

World Rank

#8073

Historical Rank

Pathology

#65

World Rank

#140

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Salvatore Pizzo's Degrees

Doctorate Medicine Harvard University
PhD Pathology Johns Hopkins University

Why Is Salvatore Pizzo Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Salvatore Vincent Pizzo is an American scientist, currently Distinguished Professor of Pathology at Duke University Medical Center and an Elected Fellow of the American Association for the Advancement of Science.

(See a Problem?)

Salvatore Pizzo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Angiostatin binds ATP synthase on the surface of human endothelial cells. (1999) (511)
Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. (1973) (424)
Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection (2003) (332)
Endothelial cell surface F1-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin (2001) (331)
Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin. (1981) (315)
Scavenger receptor‐A mediates gp96/GRP94 and calreticulin internalization by antigen‐presenting cells (2003) (281)
Activation and Cross-talk between Akt, NF-κB, and Unfolded Protein Response Signaling in 1-LN Prostate Cancer Cells Consequent to Ligation of Cell Surface-associated GRP78* (2006) (252)
GRP78: a multifunctional receptor on the cell surface. (2009) (228)
Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. (1980) (218)
Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. (1989) (216)
The effect of plasmin on the subunit structure of human fibrin. (1973) (216)
Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides (2001) (209)
Mast cell activators: a new class of highly effective vaccine adjuvants (2008) (199)
Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. (1991) (197)
A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin. (1983) (191)
alpha(2)-Macroglobulin from rheumatoid arthritis synovial fluid: functional analysis defines a role for oxidation in inflammation. (2001) (188)
GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. (2008) (187)
Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. (1977) (183)
alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. (1994) (180)
Binding of Activated α2-Macroglobulin to Its Cell Surface Receptor GRP78 in 1-LN Prostate Cancer Cells Regulates PAK-2-dependent Activation of LIMK* (2005) (180)
Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. (1979) (167)
Analysis of inter-alpha-trypsin inhibitor and a novel trypsin inhibitor, pre-alpha-trypsin inhibitor, from human plasma. Polypeptide chain stoichiometry and assembly by glycan. (1989) (159)
The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. (1971) (153)
Physical properties of human α2-macroglobulin following reaction with methylamine and trypsin (1982) (152)
Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. (2006) (150)
Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis (2008) (149)
Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults. (1980) (149)
Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer (2013) (146)
SREC-I, a Type F Scavenger Receptor, Is an Endocytic Receptor for Calreticulin* (2004) (143)
Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-bisphosphate in murine peritoneal macrophages. (1987) (141)
The subunit structure of normal and hemophilic factor VIII. (1973) (141)
Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor. (1991) (140)
The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). (1971) (137)
The in vivo metabolism of antithrombin III and antithrombin III complexes. (1982) (135)
The role of Grp 78 in alpha 2-macroglobulin-induced signal transduction. Evidence from RNA interference that the low density lipoprotein receptor-related protein is associated with, but not necessary for, GRP 78-mediated signal transduction. (2002) (134)
Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells (2008) (132)
Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated (2005) (124)
Cadmium-induced DNA synthesis and cell proliferation in macrophages: the role of intracellular calcium and signal transduction mechanisms. (2002) (123)
Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin). (1991) (119)
Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinoma (1994) (118)
Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen. (1989) (117)
Selective diminution of the binding of mannose by murine macrophages in the late stages of activation. (1982) (113)
Immunochemical and biochemical characterization of a glioma‐associated extracellular matrix glycoprotein (1985) (109)
The Role of MTJ-1 in Cell Surface Translocation of GRP78, a Receptor for α2-Macroglobulin-Dependent Signaling1 (2005) (108)
Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. (1990) (107)
Model of alpha 2-macroglobulin structure and function. (1985) (105)
Cell surface F1Fo ATP synthase: a new paradigm? (2006) (105)
Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. (1994) (105)
Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the αA2β1 integrin (1996) (103)
Evidence for a second alpha 2-macroglobulin receptor. (1994) (103)
Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. (1978) (103)
The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model (2009) (100)
Subunit structure of fragment D from fibrinogen and cross-linked fibrin. (1973) (100)
Cutting Edge: CD91-Independent Cross-Presentation of GRP94(gp96)-Associated Peptides1 (2002) (100)
REVIEW: Methionine Sulfoxide and the Oxidative Regulation of Plasma Proteinase Inhibitors (1988) (97)
Receptors for maleylated proteins regulate secretion of neutral proteases by murine macrophages. (1982) (97)
Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. (2006) (96)
Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. (1983) (96)
Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells. (1993) (95)
Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis (2009) (94)
The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. (1993) (93)
The Voltage-dependent Anion Channel Is a Receptor for Plasminogen Kringle 5 on Human Endothelial Cells* (2003) (90)
A novel receptor function for the heat shock protein Grp78: silencing of Grp78 gene expression attenuates alpha2M*-induced signalling. (2004) (89)
An Inhibitor of the F1 Subunit of ATP Synthase (IF1) Modulates the Activity of Angiostatin on the Endothelial Cell Surface* (2004) (89)
Protease-activated receptor-2 signaling triggers dendritic cell development. (2003) (88)
Oxidized Low Density Lipoprotein Suppresses Activation of NFκB in Macrophages via a Pertussis Toxin-sensitive Signaling Mechanism (*) (1995) (87)
Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin. (1993) (87)
Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. (1996) (86)
Coordinate Regulation of Forskolin-induced Cellular Proliferation in Macrophages by Protein Kinase A/cAMP-response Element-binding Protein (CREB) and Epac1-Rap1 Signaling (2005) (85)
Alpha-macroglobulin from Limulus polyphemus exhibits proteinase inhibitory activity and participates in a hemolytic system. (1990) (84)
Endothelial Cell Surface ATP Synthase-Triggered Caspase-Apoptotic Pathway Is Essential for K1-5-Induced Antiangiogenesis (2004) (84)
A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function. (1985) (83)
Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors. (1983) (81)
Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. (1997) (81)
Cytokine profiling for prediction of symptomatic radiation-induced lung injury. (2005) (79)
Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. (1982) (78)
Oxidized alpha2-macroglobulin (alpha2M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation. (1998) (77)
Murine Low-Density Lipoprotein Receptor-Related Protein 1 (LRP) Is Required for Phagocytosis of Targets Bearing LRP Ligands but Is Not Required for C1q-Triggered Enhancement of Phagocytosis1 (2008) (77)
The relationship between low density lipoprotein-related protein/alpha 2-macroglobulin (alpha 2M) receptors and the newly described alpha 2M signaling receptor. (1994) (77)
Regulation of plasminogen activation by components of the extracellular matrix. (1990) (76)
Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells (2010) (75)
Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. (2001) (73)
The effect of plasmin on the subunit structure of human fibrinogen. (1972) (73)
Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. (1972) (72)
In vivo catabolism of α1-proteinase inhibitor-trypsin, antithrombin III-thrombin and α2-macroglobulin-methylamine (1982) (69)
Receptor-recognized alpha 2-macroglobulin-methylamine elevates intracellular calcium, inositol phosphates and cyclic AMP in murine peritoneal macrophages. (1993) (69)
Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy (2014) (68)
The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. (1981) (68)
Apolipoprotein E and mimetic peptide initiate a calcium‐dependent signaling response in macrophages (2001) (67)
Modulation of the unfolded protein response in prostate cancer cells by antibody-directed against the carboxyl-terminal domain of GRP78 (2010) (67)
Ligation of Prostate Cancer Cell Surface GRP78 Activates a Proproliferative and Antiapoptotic Feedback Loop (2010) (67)
CROSS‐LINKING OF FIBRIN BY FIBRIN‐STABILIZING FACTOR * (1972) (66)
Complexes of serum albumin and cis-dichlorodiammineplatinum (II). The role of cysteine 34 as a nucleophilic entering group and evidence for reaction between bound platinum and a second macromolecule. (1983) (66)
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. (1978) (66)
The Modified Patient and Observer Scar Assessment Scale: A Novel Approach to Defining Pathologic and Nonpathologic Scarring (2011) (65)
Epac1‐induced cellular proliferation in prostate cancer cells is mediated by B‐Raf/ERK and mTOR signaling cascades (2009) (65)
Photoreactivation of irreversibly inhibited serine proteinases (1988) (64)
Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. (1989) (63)
Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. (2001) (62)
Lipoprotein(a) and its role in atherothrombotic disease. (1993) (61)
A conserved region in alpha-macroglobulins participates in binding to the mammalian alpha-macroglobulin receptor. (1989) (61)
Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. (1986) (59)
Proteinase binding and inhibition by the monomeric alpha-macroglobulin rat alpha 1-inhibitor-3. (1989) (59)
Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin. (1982) (59)
Purification and characterization of an alpha-macroglobulin proteinase inhibitor from the mollusc Octopus vulgaris. (1992) (57)
Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. (1994) (57)
Immunohistochemical Detection of Factor VIII/von Willebrand Factor in Hyperplastic Endothelial Cells in Glioblastoma Multiforme and Mixed Glioma‐Sarcoma (1982) (57)
Induction of mitogenic signalling in the 1LN prostate cell line on exposure to submicromolar concentrations of cadmium+. (2003) (56)
A CD91-Positive Subset of CD11c+ Blood Dendritic Cells: Characterization of the APC that Functions to Enhance Adaptive Immune Responses against CD91-Targeted Antigens 1 (2004) (56)
The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding. (2000) (55)
A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice (2012) (55)
Selective Mutations in Cloned and Expressed α-Macroglobulin Receptor Binding Fragment Alter Binding to Either the α2-Macroglobulin Signaling Receptor or the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor* (1996) (54)
Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding. (1991) (54)
Plasminogen Structural Domains Exhibit Different Functions When Associated with Cell Surface GRP78 or the Voltage-dependent Anion Channel* (2007) (54)
Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. (1979) (54)
Lipoprotein (a): The link between impaired fibrinolysis and atherosclerosis (1991) (54)
Potentiation of signal transduction mitogenesis and cellular proliferation upon binding of receptor-recognized forms of alpha2-macroglobulin to 1-LN prostate cancer cells. (2004) (54)
α2‐Macroglobulin: A Sensor for Proteolysis (1994) (53)
Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding. (1991) (51)
In vivo catabolism of α1-antichymotrypsin is mediated by the Serpin receptor which binds α1-proteinase inhibitor, antithrombin III and heparin cofactor II (1988) (51)
The binding of fucose-containing glycoproteins by hepatic lectins. Re-examination of the clearance from blood and the binding to membrane receptors and pure lectins. (1986) (50)
Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. (1990) (49)
Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation. (1994) (49)
Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5‐trisphosphate binding to its receptor (1997) (48)
Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain. (1991) (48)
The potential role of alpha 2-macroglobulin in the control of cysteine proteinases (gingipains) from Porphyromonas gingivalis. (1997) (48)
Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. (1987) (48)
Functional inactivation and structural disruption of human alpha 2-macroglobulin by neutrophils and eosinophils. (1989) (47)
Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. (1995) (47)
Binding of α2-macroglobulin to hepatocytes: mechanism of in vivo clearance (1985) (47)
Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. (2007) (46)
Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II). (1984) (46)
Conformation and protease binding activity of binary and ternary human alpha 2-macroglobulin-protease complexes. (1983) (46)
Regulation of Cytosolic Phospholipase A2 Activity in Macrophages Stimulated with Receptor-recognized Forms of α2-Macroglobulin (2002) (46)
Characterization of functional human alpha 2-macroglobulin half-molecules isolated by limited reduction with dithiothreitol. (1983) (46)
Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. (1990) (46)
Low-Carbohydrate Diets and Prostate Cancer: How Low Is “Low Enough”? (2010) (46)
Alpha 2-macroglobulin 'fast' forms inhibit superoxide production by activated macrophages. (1983) (46)
Activated Human Plasma Carboxypeptidase B Is Retained in the Blood by Binding to α2-Macroglobulin and Pregnancy Zone Protein* (1996) (45)
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor. (2008) (45)
Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain. (1993) (45)
Photochemical activation of acylated .alpha.-thrombin (1987) (45)
Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis. (2001) (45)
Clearance and binding of native and defucosylated lactoferrin. (1983) (44)
The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a). (1991) (44)
Interactions between cytokines and α2-macroglobulin (1991) (44)
Mechanism of hypochlorite-mediated inactivation of proteinase inhibition by alpha 2-macroglobulin. (1999) (43)
A Plasma Membrane-associated Component of Ovarian Adenocarcinoma Cells Enhances the Catalytic Efficiency of Matrix Metalloproteinase-2 (*) (1995) (43)
Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. (1981) (43)
Coordinate Regulation of the α2-Macroglobulin Signaling Receptor and the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor by Insulin* (1999) (42)
Angiostatin and anti-angiogenic therapy in human disease. (2004) (42)
Binding of Receptor-recognized Forms of α2-Macroglobulin to the α2-Macroglobulin Signaling Receptor Activates Phosphatidylinositol 3-Kinase* (1998) (42)
Ligation of the alpha 2-macroglobulin signalling receptor on macrophages induces protein phosphorylation and an increase in cytosolic pH. (1995) (42)
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer (2012) (41)
Modulation of mouse peritoneal macrophage Ia and human peritoneal macrophage HLA-DR expression by alpha 2-macroglobulin "fast" forms. (1987) (41)
In vitro binding and in vivo clearance of human alpha 2-macroglobulin after reaction with endoproteases from four different classes. (1983) (41)
Binding of human plasminogen to basement-membrane (type IV) collagen. (1992) (41)
Comparison of the binding of chicken α-macroglobulin and ovomacroglobulin to the mammalian α2-macroglobulin receptor (1984) (40)
The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model (2013) (40)
Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? (2006) (40)
Upregulation of mTORC2 activation by the selective agonist of EPAC, 8‐CPT‐2Me‐cAMP, in prostate cancer cells: Assembly of a multiprotein signaling complex (2012) (39)
LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells (2006) (39)
Ligation of Cell Surface-Associated Glucose-Regulated Protein 78 by Receptor-Recognized Forms of α2-Macroglobulin: Activation of p21-Activated Protein Kinase-2-Dependent Signaling in Murine Peritoneal Macrophages1 (2005) (39)
Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26. (2005) (38)
Evidence for a Novel O-Linked Sialylated Trisaccharide on Ser-248 of Human Plasminogen 2* (1997) (38)
Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor. (1996) (38)
Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin. (1996) (38)
Re-Examination of CD91 Function in GRP94 (Glycoprotein 96) Surface Binding, Uptake, and Peptide Cross-Presentation (2010) (37)
Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium. (1994) (37)
Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78 (2015) (37)
Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor. (1987) (37)
Maleylated‐BSA induces hydrolysis of PIP2, fluxes of Ca2+, NF‐κB binding, and transcription of the TNF‐α gene in murine macrophages (1996) (36)
Severe combined immunodeficiency with leukopenia (reticular dysgenesis) in siblings: immunologic and histopathologic findings. (1976) (36)
Preparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal species (1988) (35)
The Mechanism of Action of Angiostatin: Can You Teach an Old Dog New Tricks? (2002) (35)
Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity. (1995) (35)
A Unique Pathway for the Plasma Elimination of α2-Antiplasmin-Protease Complexes in Mice (1982) (35)
Up‐regulation of GRP78 and antiapoptotic signaling in murine peritoneal macrophages exposed to insulin (2005) (35)
Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. (1991) (35)
Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins. (1988) (35)
Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis. (1986) (34)
Ligation of low-density lipoprotein receptor-related protein with antibodies elevates intracellular calcium and inositol 1,4, 5-trisphosphate in macrophages. (1999) (34)
Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma (2010) (33)
Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma (2011) (33)
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell‐line specific manner, through paradoxical effects on oncogenic pathways (2013) (33)
Reaction of human alpha 2-macroglobulin half-molecules with plasmin as a probe of protease binding site structure. (1983) (33)
In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors. (1988) (32)
Receptor-Recognized α2-Macroglobulin Binds to Cell Surface-Associated GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer Cells (2012) (32)
In Vitro Preparation of Nonenzymatically Glucosylated Human Transferrin, α2-Macroglobulin, and Fibrinogen with Preservation of Function (1985) (32)
Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. (1991) (32)
The role of carbohydrate in the function of human plasminogen: comparison of the protein obtained from molecular cloning and expression in Escherichia coli and COS cells. (1990) (31)
Blood coagulation and idiopathic thromboembolism among fertile women. (1980) (31)
Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism (2010) (31)
Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. (2005) (31)
Identification of "embryonin" as bovine alpha 2-macroglobulin. (1984) (30)
Evidence for a Pro-Proliferative Feedback Loop in Prostate Cancer: The Role of Epac1 and COX-2-Dependent Pathways (2013) (30)
Selective upregulated expression of the alpha2-macroglobulin signaling receptor in highly metastatic 1-LN prostate carcinoma cells. (2000) (30)
Ligation of the alpha2M signalling receptor elevates the levels of p21Ras-GTP in macrophages. (1998) (30)
Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets. (1980) (30)
Ligation of the alpha2M signaling receptor with receptor-recognized forms of alpha2-macroglobulin initiates protein and DNA synthesis in macrophages. The effect of intracellular calcium. (1998) (30)
CHEMICAL AND STRUCTURAL MODIFICATIONS OF α2‐MACROGLOBULIN: EFFECTS ON RECEPTOR BINDING AND ENDOCYTOSIS STUDIED IN AN IN VIVO MODEL a (1983) (30)
Modulation of platelet shape and membrane receptor binding by Ca2+–calmodulin complex (1981) (29)
Glucose‐regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders (2021) (29)
Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3. (1985) (29)
Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells. (2002) (29)
Inactivation of the plasma protease inhibitor alpha 2-macroglobulin by the antitumor drug cis-dichlorodiamineplatinum(II). (1981) (29)
Purification of an almond emulsin fucosidase on Cibacron blue-sepharose and demonstration of its activity toward fucose-containing glycoproteins. (1982) (29)
Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. (1988) (29)
The Binding of Receptor-recognized α2-Macroglobulin to the Low Density Lipoprotein Receptor-related Protein and the α2M Signaling Receptor Is Decoupled by Oxidation* (1997) (29)
Activated α2-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein* (2016) (29)
Nickel inhibits binding of alpha2-macroglobulin-methylamine to the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor but not the alpha2-macroglobulin signaling receptor. (1997) (28)
Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology. (1990) (28)
Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells (2015) (28)
The Role of cAMP-dependent Signaling in Receptor-recognized Forms of α2-Macroglobulin-induced Cellular Proliferation* (2002) (28)
Identification of monomeric α-macroglobulin proteinase inhibitors in birds, reptiles, amphibians and mammals, and purification and characterization of a monomeric α-macroglobulin proteinase inhibitor from the American bullfrog Rana catesbiana (1993) (27)
Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site. (1986) (27)
Elevated urokinase‐type plasminogen activator level and bleeding in amyloidosis: Case report and literature review (1989) (27)
Sialic Acid Content of Plasminogen 2 Glycoforms as a Regulator of Fibrinolytic Activity (1995) (27)
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF. (2002) (27)
A colorimetric assay for releasable plasminogen activator. (1982) (27)
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance (2015) (26)
Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions. (2003) (26)
Inflammatory Cells Degrade Inter‐α Inhibitor to Liberate Urinary Proteinase Inhibitors (1989) (25)
Antigen delivery by α2‐macroglobulin enhances the cytotoxic T lymphocyte response (2009) (25)
An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin. (1993) (25)
Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling (2019) (25)
Mechanism of action of inter-alpha-trypsin inhibitor. (1987) (25)
Heterotrimeric Gαq11 co‐immunoprecipitates with surface‐anchored GRP78 from plasma membranes of α2M*‐stimulated macrophages (2008) (25)
Hepatocyte uptake of α1‐proteinase inhibitor‐trypsin complexes in vitro: Evidence for a shared uptake mechanism for proteinase complexes of α1‐proteinase inhibitor and antithrombin III (1984) (24)
Upregulation of macrophage plasma membrane and nuclear phospholipase D activity on ligation of the alpha2-macroglobulin signaling receptor: involvement of heterotrimeric and monomeric G proteins. (1999) (24)
Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts. (1993) (24)
Low-Density Lipoprotein Receptor-Related Protein/ α2-Macroglobulin Receptor on Murine Peritoneal Macrophages Mediates the Binding and Catabolism of Low-Density Lipoprotein (1996) (24)
In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. (2013) (24)
cis-dichlorodiammineplatinum (II) as a selective modifier of the oxidation-sensitive reactive-center methionine in alpha 1-antitrypsin. (1988) (23)
Fluorescent probes as a measure of conformational alterations induced by nucleophilic modification and proteolysis of bovine alpha 2-macroglobulin. (1984) (23)
Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores* (2010) (23)
Covalent complexes of antigen and alpha(2)-macroglobulin: evidence for dramatically-increased immunogenicity. (2001) (23)
Cell surface GRP78 signaling: An emerging role as a transcriptional modulator in cancer (2020) (22)
The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: Gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages. (2008) (22)
The Escherichia coli Subtilase Cytotoxin A Subunit Specifically Cleaves Cell-surface GRP78 Protein and Abolishes COOH-terminal-dependent Signaling (2012) (22)
The clearance of glycoproteins in diabetic mice. (1981) (22)
Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus (2015) (22)
Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products. (1986) (22)
Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival (2011) (22)
Transcatheter electrocoagulation: a therapeutic angiographic technique for vessel occlusion. (1976) (22)
Releasable vascular plasminogen activator and thrombotic strokes. (1985) (22)
Sodium Dodecyl Sulfate-stable Complexes between Serpins and Active or Inactive Proteinases Contain the Region COOH-terminal to the Reactive Site Loop (*) (1995) (22)
Modulation of the unfolded protein response by GRP78 in prostate cancer. (2011) (22)
Association of Plasminogen with Dipeptidyl Peptidase IV and Na+/H+ Exchanger Isoform NHE3 Regulates Invasion of Human 1-LN Prostate Tumor Cells* (2005) (22)
Inhibition of NF-kappaB1 and NF-kappaB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: effect of p53 upregulation. (2010) (21)
BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo. (2016) (21)
Activated α2-Macroglobulin Binding to Human Prostate Cancer Cells Triggers Insulin-like Responses (2015) (21)
In vivo metabolism of inter-α-trypsin inhibitor and its proteinase complexes: Evidence for proteinase transfer to α2-macroglobulin and α1-proteinase inhibitor (1986) (21)
Venous and arterial thromboembolic disease in women using oral contraceptives. (1982) (21)
α2‐Macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor‐dependent mechanism (2008) (21)
Targeting cell surface F1F0 ATP synthase in cancer therapy (2008) (21)
Evidence that the platinum-reactive methionyl residue of the alpha 2-macroglobulin receptor recognition site is not in the carboxyl-terminal receptor binding domain. (1988) (21)
Purification and characterization of a "half-molecule" alpha 2-macroglobulin from the southern grass frog: absence of binding to the mammalian alpha 2-macroglobulin receptor. (1986) (21)
Alpha 2-macroglobulin: a sensor for proteolysis. (1994) (21)
Preparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal species. (1988) (20)
Circular dichroic spectroscopy of non-human α-macroglobulins☆ (1984) (20)
The effect of zinc and other divalent cations on the structure and function of human α2-macroglobulin (1984) (20)
Characterization of alpha 2-macroglobulin-plasmin complexes: complete subunit cleavage alters receptor recognition in vivo and in vitro. (1987) (20)
Is there a precursive, relatively procoagulant-inactive form of normal antihemophilic factor (factor VIII)? (1979) (20)
Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin. (1993) (20)
Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model (2017) (20)
Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse. (1990) (20)
Electron microscopic identification of exposed plasmin epitopes in alpha 2-macroglobulin-plasmin complex using monoclonal antibody-colloidal gold adducts. (1988) (20)
Fibrinolytic response and oral contraceptive associated thromboembolism. (1981) (20)
536: Effect of Diet on Lncap Prostate Cancer Growth and Survival in Scid Mice (2007) (20)
PFT-alpha inhibits antibody-induced activation of p53 and pro-apoptotic signaling in 1-LN prostate cancer cells. (2010) (19)
Complexes between serpins and inactive proteinases are not thermodynamically stable but are recognized by serpin receptors. (1994) (19)
ROS-independent Nrf2 activation in prostate cancer (2017) (19)
Characterization of fragment E from fibrinogen and cross-linked fibrin. (1976) (19)
Lipoprotein (a) regulates plasmin generation and inhibition. (1994) (19)
Binding and endocytosis of alpha 2-macroglobulin-plasmin complexes. (1985) (18)
Effect of methylamine and plasmin on the conformation of human alpha 2-macroglobulin as revealed by differential scanning calorimetric analysis. (1984) (18)
Nonproteolytic incorporation of protein ligands into human alpha 2-macroglobulin: implications for the binding mechanism of alpha 2-macroglobulin. (1998) (18)
Use of anti-idiotypic antibodies to establish that monoclonal antibody 7H11D6 binds to the alpha 2-macroglobulin receptor recognition site. (1988) (18)
Beryllium fluoride‐induced cell proliferation: a process requiring P21ras‐dependent activated signal transduction and NF‐κB‐dependent gene regulation (2002) (18)
In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II. (1988) (18)
Down regulation of macrophage mannose/N-acetylglucosamine receptors by elevated glucose concentrations. (1983) (18)
Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer (2018) (18)
Streptokinase and human fibronectin share a common epitope: implications for regulation of fibrinolysis and rheumatoid arthritis. (1993) (18)
Cell Surface Adenosine Deaminase Binds and Stimulates Plasminogen Activation on 1-LN Human Prostate Cancer Cells* (2004) (17)
Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect (2017) (17)
Immunohistochemical studies of cell differentiation in a juxtaglomerular tumor. (1982) (17)
Intersubunit cross-linking by cis-dichlorodiammineplatinum(II) stabilizes an alpha 2-macroglobulin "nascent" state: evidence that thiol ester bond cleavage correlates with receptor recognition site exposure. (1988) (17)
Expression of a functional α‐macroglobulin receptor binding domain in Escherichia coli (1992) (17)
Upregulation of autophagy genes and the unfolded protein response in human heart failure. (2017) (17)
Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores. (2015) (17)
Binding of rat α1‐inhibitor‐3‐methylamine to the α2‐macroglobulin signaling receptor induces second messengers (1996) (17)
Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin. (1992) (16)
Ligation of α2M Receptors with α2M‐Methylamine Stimulates the Activities of Phospholipase C, Phospholipase A2, and Protein Kinase C in Murine Peritoneal Macrophages (1994) (16)
The Role of Grp 78 in α2-Macroglobulin-induced Signal Transduction (2002) (16)
Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. (2005) (16)
Evaluation of the rapid plasma elimination of recombinant alpha 1-proteinase inhibitor: synthesis of polyethylene glycol conjugates with improved therapeutic potential. (1990) (16)
Cyclosporin A inhibits inositol 1,4,5-trisphosphate binding to its receptors and release of calcium from intracellular stores in peritoneal macrophages. (1998) (16)
Purification and characterization of frog alpha-macroglobulin: receptor recognition of an amphibian glycoprotein. (1985) (16)
Binding of Tissue-type Plasminogen Activator to the Glucose-regulated Protein 78 (GRP78) Modulates Plasminogen Activation and Promotes Human Neuroblastoma Cell Proliferation in Vitro* (2014) (16)
The Voltage-dependent Anion Channel (VDAC) Binds Tissue-type Plasminogen Activator and Promotes Activation of Plasminogen on the Cell Surface (2012) (16)
Transcatheter electrocoagulation: experimental evaluation of the anode. (1979) (16)
Comparison of plasminogen binding and activation on extracellular matrices produced by vascular smooth muscle and endothelial cells. (1994) (15)
Hepatocyte receptors for antithrombin III‐proteinase complexes (1984) (15)
The exposure of murine macrophages to alpha 2-macroglobulin 'fast' forms results in the rapid secretion of eicosanoids. (1991) (15)
Simple and sensitive assay employing stable reagents for quantification of plasminogen activator. (1981) (15)
Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis (1996) (15)
Limited proteolysis of the alpha-macroglobulin rat alpha 1-inhibitor-3. Implications for a domain structure. (1991) (15)
In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. (1985) (15)
Defective release of tissue plasminogen activator in patients with sickle cell anemia (1988) (15)
Activated α2-Macroglobulin Binding to Cell Surface GRP78 Induces T-Loop Phosphorylation of Akt1 by PDK1 in Association with Raptor (2014) (15)
Structural and functional analysis of the spontaneous re-formation of the thiol ester bond in human alpha 2-macroglobulin, rat alpha 1-inhibitor-3 and chemically modified derivatives. (1996) (15)
Inducible expression of the α2‐macroglobulin signaling receptor in response to antigenic stimulation: A study of second messenger generation (2001) (14)
Independent analysis of bait region cleavage dependent and thiolester bond cleavage dependent conformational changes by cross-linking of alpha 2-macroglobulin with cis-dichlorodiammineplatinum(II) and dithiobis(succinimidyl propionate). (1989) (14)
Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation. (1991) (14)
Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor (2017) (14)
Interaction between TCL1 and Epac1 in the activation of Akt kinases in plasma membranes and nuclei of 8-CPT-2-O-Me-cAMP-stimulated macrophages. (2008) (14)
Activation of Akt/PDK signaling in macrophages upon binding of receptor‐recognized forms of α2‐macroglobulin to its cellular receptor: Effect of silencing the CREB gene (2004) (14)
The Endoplasmic Reticulum Chaperone GRP78 Also Functions as a Cell Surface Signaling Receptor (2018) (14)
Changes in the binding of "fast"-form alpha 2-macroglobulin to 3T3-L1 cells after differentiation to adipocytes. (1984) (14)
Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence (2018) (13)
The monomeric receptor binding domain of tetrameric α2-macroglobulin binds to cell surface GRP78 triggering equivalent activation of signaling cascades. (2013) (13)
Dipeptidyl peptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts (1998) (13)
A Comparative Study of Crosslinked and Noncrosslinked Fibrin from the Major Classes of Vertebrates (1973) (13)
Characterization of α2-Macroglobulin Binding to Human Trabecular Meshwork Cells: Presence of the α2-Macroglobulin Signaling Receptor (1996) (13)
Trypanosoma brucei gambiense: growth in vitro of bloodstream forms inhibited by dichlorodiammineplatinum (II) compounds and hypolipidemic drugs. (1985) (13)
Localization of factor VIII/von willebrand factor and glial fibrillary acidic protein in the hemangioblastoma: Implications for stromal cell histogenesis (2004) (13)
Inflammatory cells degrade inter-alpha inhibitor to liberate urinary proteinase inhibitors. (1989) (13)
The role of inter-alpha-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin. (1987) (13)
α1-Microglobulin Destroys the Proteinase Inhibitory Activity of α1-Inhibitor-3 by Complex Formation (*) (1995) (13)
A radioreceptor assay for quantitating plasma factor VIII/von Willebrand's protein. (1981) (13)
Induction of cyclooxygenase-2 synthesis by ligation of the macrophage alpha(2)-macroglobulin signalling receptor. (2001) (13)
Kinetics of Nonproteolytic Incorporation of a Protein Ligand into Thermally Activated α2-Macroglobulin (2001) (13)
Effect of desialylation on the biological properties of human plasminogen. (1992) (12)
Conformation-specific precipitation of human alpha 2-macroglobulin by divalent zinc or calf thymus histone H3. (1984) (12)
Clearance and Distribution of Recombinant Murine γ-Interferon in Mice (1988) (12)
Altered clearance of human alpha 2-macroglobulin complexes following reaction with cis-dichlorodiamineplatinum(II). (1981) (12)
Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase (1991) (12)
Coordinate regulation of the alpha(2)-macroglobulin signaling receptor and the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor by insulin. (1999) (12)
Mesenteric vein thrombosis and vascular plasminogen activator. (1983) (12)
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface (2016) (12)
PLASMIN(OGEN) CARBOHYDRATE CHAINS MEDIATE BINDING TO DIPEPTIDYL PEPTIDASE IV (CD 26) IN RHEUMATOID ARTHRITIS HUMAN SYNOVIAL FIBROBLASTS (1998) (12)
The Role of Endothelium in Factor Xa Regulation: The Effect of Plasma Proteinase Inhibitors and Hirudin (1988) (12)
Upregulation of AKT1 protein expression in forskolin‐stimulated macrophage: Evidence from ChIP analysis that CREB binds to and activates the AKT1 promoter (2007) (11)
Analysis of thiolester bond cleavage-dependent conformational changes in binary alpha 2-macroglobulin-proteinase complexes. (1988) (11)
Cytosolic Phospholipase A2 Activity Associated with Nuclei Is Not Inhibited by Arachidonyl Trifluoromethyl Ketone in Macrophages Stimulated with Receptor-Recognized Forms of α2-Macroglobulin (2000) (11)
Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II). (1988) (11)
Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies. (1984) (11)
Why is lipoprotein(a) relevant to thrombosis? (1992) (11)
In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine. (1982) (10)
Specificity of alpha 2-macroglobulin covalent cross-linking for the active domain of proteinases. (1986) (10)
The bleeding diathesis in human glycogen storage disease type I: in vitro identification of a naturally occurring inhibitor of ristocetin-induced platelet aggregation. (1980) (10)
Streptokinase Promotes Development of Dipeptidyl Peptidase IV (CD26) Autoantibodies after Fibrinolytic Therapy in Myocardial Infarction Patients (2002) (10)
Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis. (1996) (10)
The biochemistry of haemostasis. (1986) (10)
The effect of divalent cations on the conformation and function of human plasminogen. (1991) (10)
Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism. (2008) (10)
Binding of receptor-recognized forms of alpha2-macroglobulin to the alpha2-macroglobulin signaling receptor activates phosphatidylinositol 3-kinase. (1998) (10)
Microassay for the photometric quantitation of cell-associated plasminogen activator using a chromogenic tripeptide substrate. (1984) (10)
Symmetry of the inhibitory unit of human alpha 2-macroglobulin. (1988) (10)
Papillary adenocarcinoma of the renal pelvis in a child: case report and brief review of the literature. (1990) (9)
Fibrinolysis and fibrinogenolysis by Val442-plasmin. (1982) (9)
Actions of thrombin in the interstitium (2016) (9)
Selective mutations in cloned and expressed alpha-macroglobulin receptor binding fragment alter binding to either the alpha2-macroglobulin signaling receptor or the low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor. (1996) (9)
Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride. (1992) (9)
Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptor. (1996) (9)
Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration (2009) (9)
Activated α2-macroglobulin binding to cell surface GRP78 induces trophoblastic cell fusion (2020) (9)
Regulation of Tissue Plasminogen Activator in Sickle Cell Anemia (1990) (9)
Physical properties of human alpha 2-macroglobulin following reaction with methylamine and trypsin. (1982) (8)
ATP-regulated activity of the plasmin-streptokinase complex: a novel mechanism involving phosphorylation of streptokinase. (1996) (8)
Lipoprotein (a) in the regulation of fibrinolysis. (1995) (8)
Increased releasable vascular plasminogen activator and a bleeding diathesis. (1984) (8)
The physiologic role of antithrombin III as an anticoagulant. Discussion (1994) (8)
Evaluation of p-Amidinophenyl Esters as Potential Antithrombotic Agents (1986) (8)
Renal carcinosarcoma. Ultrastructure and transplantation into athymic mice. (1980) (8)
Receptor-recognized 2-macroglobulin-methylamine elevates intracellular calcium, inositol phosphates and cyclic AMP in murine peritoneal macrophages (2005) (7)
Vascular regulation of plasminogen activator inhibitor-1 activity. (1994) (7)
Ligation of the alpha2M* signaling receptor regulates synthesis of cytosolic phospholipase A2. (2001) (7)
Incorporation of non-proteolytic proteins by murine α2-macroglobulin (1999) (7)
Polyethylene glycol modification of serpins improves therapeutic potential. (1990) (7)
Ligation of the α2‐macroglobulin signaling receptor on macrophages induces synthesis of platelet activating factor (1996) (7)
The Clearance of Human Fibrinogen Fragments X and Y in Mice: A Process Mediated by the Fragment D Receptor (1983) (7)
Purification and characterization of human α2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography (1986) (7)
Exposure of cultured murine peritoneal macrophages to low concentrations of beryllium induces increases in intracellular calcium concentrations and stimulates DNA synthesis (1999) (7)
In vivo metabolism of reversibly inhibited α-thrombin (1983) (7)
ROS-independent Nrf2 activation in prostate cancer. (2017) (7)
Membrane protein mediation of thromboxane A2-induced platelet aggregation. (1980) (7)
The role of carbohydrate in the activation of plasminogen 2 glycoforms by streptokinase (1996) (7)
Comparison of Ancrod and Heparin as Anticoagulants Following Endarterectomy in the Dog (1976) (7)
Potentiation of calcium levels by extracellular arachidonic acid in nuclei isolated from macrophages stimulated with receptor-recognized forms of alpha(2)-macroglobulin. (2000) (6)
Photochemical Activation of Acylated α-Thrombin (1987) (6)
Characterization of human alpha 2-macroglobulin monomers obtained by reduction with dithiothreitol. (1991) (6)
The effect of drug-induced thrombocytopenia on direct-current transcatheter electrocoagulation. (1977) (6)
Binding of alpha 2-macroglobulin to hepatocytes: mechanism of in vivo clearance. (1985) (6)
The role of histidyl residues in zinc-induced precipitation of alpha 2-macroglobulin-proteinase complexes. (1987) (6)
Anti-Inflammatory and Vasoprotective Activity of a Retroviral-Derived Peptide, Homologous to Human Endogenous Retroviruses: Endothelial Cell Effects (2012) (6)
The temperature-dependent reaction between alpha 2-macroglobulin and streptokinase-plasmin(ogen) complex. (1987) (6)
An Historical Perspective: Cell Surface GRP78, a New Paradigm in Signal Transduction Biology (2018) (6)
Low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor on murine peritoneal macrophages mediates the binding and catabolism of low-density lipoprotein. (1996) (6)
Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters. (1980) (6)
Incorporation of low molecular weight molecules into α2-Macroglobulin by nucleophilic exchange (2007) (5)
Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease (2022) (5)
Incorporation of low molecular weight molecules into alpha(2)-macroglobulin by nucleophilic exchange. (2007) (5)
Probing the stability of native and activated forms of α2-macroglobulin (2008) (5)
Receptor-associated protein binding blocks ubiquitinylation of the low density lipoprotein receptor-related protein. (2001) (5)
Alpha 2 macroglobulin-proteinase complexes stimulate prostaglandin E2 synthesis by peritoneal macrophages. (1988) (5)
Partial purification and characterization of a murine glioma-associated antigen defined by syngeneic rat monoclonal antibodies (1986) (5)
The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen. (1994) (5)
Effect of interferon-γ and human α2-macroglobulin on peritoneal macrophage morphology and Ia antigen expression (1990) (5)
Heparin as an hyperbolic modulator of plasminogen activation by t-PA (1994) (5)
Lack of thromboxane A2 synthesis in platelet aggregation induced by factor VIII/von Willebrand factor. (1981) (5)
GRP78 (BiP): A Multifunctional Cell Surface Receptor (2012) (5)
The Properties of Rabbit α1-Macroglobulin upon Activation Are Distinct from Those of Rabbit and Human α2-Macroglobulins (2005) (5)
α2Macroglobulin-proteinase complexes stimulate prostaglandin E2 synthesis by peritoneal macrophages (1988) (4)
Clearance and distribution of recombinant murine gamma-interferon in mice. (1988) (4)
Polypeptide Chain Structure of Inter-α-Trypsin Inhibitor and Pre-α-Trypsin Inhibitor: Evidence for Chain Assembly by Glycan and Comparison with other “Kunin”-Containing Proteins (1990) (4)
Identification of monomeric alpha-macroglobulin proteinase inhibitors in birds, reptiles, amphibians and mammals, and purification and characterization of a monomeric alpha-macroglobulin proteinase inhibitor from the American bullfrog Rana catesbeiana. (1993) (4)
Tissue plasminogen activator deficiency: A molecular analysis (1987) (4)
113 IMMUNOPEROXIDASE DETECTION OF FACTOR VIII/VON WILLEBRAND FACTOR (FVIII/vWF) IN GLIOBLASTOMA MULTIFORME (GBM), MIXED GLIOMA-SARCOMA (GS), HEMAN-GIOBLASTOMA (HBL), AND MENINGEAL HEMANGIOPERICYTOMA (HP) (1981) (4)
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells (2010) (4)
α2-macroglobulin co-administered in vivo promotes antigen delivery and presentation (2012) (4)
New member of the trefoil factor family of proteins is an α-macroglobulin protease inhibitor (2002) (4)
Identification of residues in α-macroglobulins involved in activation of the α2-macroglobulin signaling receptor (1996) (4)
Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease (2021) (3)
ATP Synthase 0 F 1 Catalytic Subunit of F Angiostatin-Like Activity of a Monoclonal Antibody to the Updated (2007) (3)
The effect of zinc and other divalent cations on the structure and function of human alpha 2-macroglobulin. (1984) (3)
Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases (2022) (3)
Appendices. Kinetic models for the analysis of modulation and suppression of irreversible enzymatic inhibition. (1991) (3)
Raptor Association with PDK1 Is Necessary for T-loop Phosphorylation of Akt in Prostate Cancer Cells Stimulated with 8-CPT-2-Me-cAMP (2013) (3)
Soluble α2-macroglobulin receptor is increased in endotracheal aspirates from infants and children after cardiopulmonary bypass (2005) (3)
Purification and subunit structure of human plasma and platelet fibrin-stabilizing factor. (1971) (3)
Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity. (1983) (3)
Alterations in calcium metabolism in murine macrophages by the benzene metabolite 1,4-benzoquinone. (1998) (3)
Model of a 2-macroglobulin structure and function ( proteinase inhibitor / a 2-macroglobulin / trap hypothesis ) (3)
A three-dimensional model of a unique proteinase inhibitor: alpha 2-macroglobulin. (1986) (3)
Modulation of Murine B 16 F 10 Melanoma Plasminogen Activator Production by a Synthetic Peptide Derived from the Laminin A Chain 1 (2006) (3)
Cytosolic phospholipase A(2) activity associated with nuclei is not inhibited by arachidonyl trifluoromethyl ketone in macrophages stimulated with receptor-recognized forms of alpha(2)-macroglobulin. (2000) (3)
When is a Proteinase Inhibitor a Hormone? The Strange Tale of α2-Macroglobulin (2015) (3)
Ligation of alpha 2M receptors with alpha 2M-methylamine stimulates the activities of phospholipase C, phospholipase A2, and protein kinase C in murine peritoneal macrophages. (1994) (3)
Peptide Cross-Presentation ( Glycoprotein 96 ) Surface Binding , Uptake , Re-Examination of CD 91 Function in GRP 94 (2010) (3)
Transcatheter electrocoagulation of the pulmonary artery: an experimental model in dogs for studying pulmonary thrombosis. (1981) (3)
Binding of rat alpha 1-inhibitor-3-methylamine to the alpha 2-macroglobulin signaling receptor induces second messengers. (1996) (3)
Interaction of urinary-type plasminogen activator with extracellular matrix proteins: Specific binding to vitronectin (1994) (3)
Effect of increasing current and decreasing blood flow for transcatheter electrocoagulation (TCEC). (1981) (3)
Proteolysis in the Interstitial Space (2016) (2)
1444 THE EFFECT OF CARBOHYDRATE RESTRICTION ON PROSTATE CANCER TUMOR GROWTH IN A CASTRATE MOUSE XENOGRAFT MODEL (2011) (2)
The properties of rabbit alpha1-macroglobulin upon activation are distinct from those of rabbit and human alpha2-macroglobulins. (2005) (2)
New member of the trefoil factor family of proteins is an alpha-macroglobulin protease inhibitor. (2002) (2)
Incorporation of non-proteolytic proteins by murine alpha2-macroglobulin. (1999) (2)
Lipoprotein (a): purification and kinetic analysis. (1993) (2)
Electron microscopy studies of alpha 2-macroglobulin subunit association after limited reduction with dithiothreitol. (1993) (2)
Minimal brain dysfunction and methylphenidate. (1971) (2)
In vivo catabolism of human heparin cofactor II and its complex with thrombin (1987) (2)
A NO CARBOHYDRATE DIET SIGNIFICANTLY PROLONGS SURVIVAL IN A PROSTATE CANCER XENOGRAFT MODEL VIA IGF-1 AND GLOBAL GENE EXPRESSION CHANGES (2009) (2)
Cytokine profiling to predict radiation-induced lung injury (2004) (2)
Life-long bleeding diathesis: effect of orthotopic liver transplantation. (1994) (2)
The antitumorigenic trifecta. (2009) (2)
Defective release of vascular plasminogen activator in patients with gynecologic malignancies. (1986) (2)
Ligation of the alpha 2-macroglobulin signaling receptor on macrophages induces synthesis of platelet activating factor. (1996) (1)
Expression of a functional alpha-macroglobulin receptor binding domain in Escherichia coli. (1992) (1)
Comparison of the binding of chicken alpha-macroglobulin and ovomacroglobulin to the mammalian alpha 2-macroglobulin receptor. (1984) (1)
Necrosis of the colon secondary to pancreatitis (1978) (1)
Identification of residues in alpha-macroglobulins involved in activation of the alpha 2-macroglobulin signaling receptor. (1996) (1)
Annexin 2/factor xa-mediated signal transduction. (2008) (1)
Analysis of kinetic and thermodynamic parameters of isolated plasminogen 2 glycoforms (1994) (1)
Carbohydrate recognition systems in amphibians: primitive alpha 2-macroglobulin receptors. (1987) (1)
Receptors on hepatocytes that bind ligands containing fucosyl α1,3 N-acetylglucosamine linkages (1980) (1)
Soluble alpha2-macroglobulin receptor is increased in endotracheal aspirates from infants and children after cardiopulmonary bypass. (2005) (1)
Receptors on hepatocytes that bind ligands containing fucosyl alpha 1,3 N-acetylglucosamine linkages. (1980) (1)
Cell Surface ATP Synthase: A Potential Target for Anti-Angiogenic Therapy (2010) (1)
In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor. (1986) (1)
Macrophages in the late stages of activation. (1982) (1)
Up-regulation of the (cid:97) 2 -Macroglobulin Signaling Receptor on Rheumatoid Synovial Fibroblasts* (1996) (1)
Chaperones and disease. (2005) (1)
iTorin1—An Active Site Inhibitor of mTOR, Suppresses Prostate Cancer Cell Growth Induced by Activated α2M-Macroglobulin Ligation of Cell Surface GRP78 (2013) (1)
138 Isolation of an angiostatin receptor from the membranes of human umbilical vein endothelial cells (1997) (1)
Effects of pimozide and penfluridol on the binding and endocytosis of alpha 2-macroglobulin-CH3NH2 by mouse peritoneal macrophages. (1984) (1)
THE EFFECT OF INCREASING CURRENT FOR TRANSCATHETER ELECTROCOAGULATION (TCEC) (1980) (1)
Nontoxic Irreversible Inhibitors of Factors IXa, Xa, and Thrombin: Potential Therapeutic Agents for the in Vivo Regulation of Thrombin Generation and Activity a (1986) (1)
Releasable tissue plasminogen activators in ischemic stroke. (1991) (1)
Probing the stability of native and activated forms of alpha2-macroglobulin. (2008) (1)
Functional Properties and in Vivo Survival of Normal and Asialo Human Factor VIII/VON Willebrand Protein (1977) (1)
Purification and characterization of human a2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography (2005) (1)
Responses against CD 91-Targeted Antigens that Functions to Enhance Adaptive Immune Dendritic Cells : Characterization of the APC Blood + A CD 91-Positive Subset of CD 11 c (2003) (0)
Reducing the risk of oral contraceptive-induced thrombosis. (1981) (0)
Abstract 5248: Tunneling nanotubes connect melanoma cells and mediate transfer of mitochondria and GRP78. (2013) (0)
in Vitro Neuroblastoma Cell Proliferation Activation and Promotes Human 78 ( GRP 78 ) Modulates Plasminogen Activator to the Glucose-regulated Protein Binding of Tissue-type Plasminogen Enzymology : (2014) (0)
Regulation of ovarian carcinoma-associaited proteinases: Cell surface-mediated proteolysis by plasma membrane localized matrix metalloproteinase-2 and urinary-type plasminogen activator (1994) (0)
Microsoft Word-Activated a2macroglobulin binding to human prostate cancer cells SS 02.11.2015 (2015) (0)
Erratum: Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores (Journal of Biological Chemistry (2010) 285 (28912-28923) DOI 10.1074/jbc.A110.119107) (2015) (0)
1437 LOW-CARBOHYDRATE DIETS AND PROSTATE CANCER GROWTH: HOW LOW IS “LOW ENOUGH”? (2010) (0)
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance (2015) (0)
Specific binding ofurinary-type plasminogen activator (u-PA) tovitronectin andits role inmediating u-PA-dependent adhesion ofU937cells (1995) (0)
In vivo metabolism of reversibly inhibited alpha-thrombin. (1983) (0)
Lipoprotein(A) regulates the rate of plasmin generation and inhibition (1992) (0)
GRP78 In Wound Healing: Molecular Mechanism And Therapeutic Potential (2011) (0)
Interactions between cytokines and alpha 2-macroglobulin. (1991) (0)
1322 THE EFFECT OF POMEGRANATE EXTRACT DOSE ON PROSTATE CANCER GROWTH IN A CARBOHYDRATE RESTRICTED MOUSE XENOGRAFT MODEL (2012) (0)
Altered Interaction of Cis- dichlorodiammineplatinum(II)–modiﬁed (cid:97) 2 -Macroglobulin ( (cid:97) 2 M) with the Low Density Lipoprotein Receptor-related Protein/ (cid:97) 2 M Receptor but Not the (cid:97) 2 M Signaling Receptor Evidence for Interference with Receptor Dissociation and Recycling (1996) (0)
Structural and functional analysis of the spontaneous re-formation of the thiol ester bond in human a 2 -macroglobulin, rat a 1 -inhibitor-3 and chemically modiﬁed derivatives (1996) (0)
The effect of substituted laminin a chain-derived peptides on the activation kinetics and zymogen conformation of plasminogen (1994) (0)
225 THE EFFECTS OF CHOLESTEROL TREATMENT DRUGS ALONE AND IN COMBINATION ON PROSTATE TUMOR XENOGRAFT GROWTH (2012) (0)
C 1 q-Triggered Enhancement of Phagocytosis LRP Ligands but Is Not Required for Required for Phagocytosis of Targets Bearing Receptor-Related Protein 1 ( LRP ) Is Murine Low-Density Lipoprotein and (2008) (0)
Upregulation of cyclooxygenase-2 in macrophages stimulated with receptor-recognized forms of α-macroglobulin (2000) (0)
Neutral proteases by murine macrophages. (1982) (0)
Angiotensin II Induces Nonmuscle Myosin II Expression and Migration in Keloid Fibroblasts (2010) (0)
Abstract 2816: Low-carbohydrate diets and prostate cancer growth: How low is “low enough” (2010) (0)
GRP 94 ( gp 96 )-Associated Peptides Cross-Presentation of Cutting Edge : CD 91-Independent (2002) (0)
145: A No-Carbohydrate Diet Significantly Delays Prostate Cancer Growth in an Animal Model (2007) (0)
Abstract 4602: Cholesterol and ezetimibe: Effects on tumor growth and survival outcomes: An interim analysis (2011) (0)
The Extracellular Matrix, Basement Membrane, and Glycocalyx (2016) (0)
Targeting Prostate Cancer Stemlike Cells through Cell Surface Expressed GRP78 (2013) (0)
686 TISSUE AMINO ACID LEVELS ARE SIGNIFICANTLY DECREASED IN MICE FED A NO-CARBOHYDRATE KETOGENIC DIET COMPARED TO WESTERN DIET (2010) (0)
Abstract POSTER-THER-1420: Ascites drives ovarian cancer stem-like cell growth: therapeutic opportunities (2015) (0)
Identification ofmonomeric x-macroglobulin proteinase inhibitors inbirds, reptiles, amphibians andmammals, andpurification andcharacterization of amonomeric a-macroglobulin proteinase inhibitor fromtheAmerican bullfrog Ranacatesbiana (1993) (0)
Interactions between amount but the distribution of sur- etics of complex formation and of cytokines and (x 2- macroglobulin (1991) (0)
Circular dichroic spectroscopy of non-human alpha-macroglobulins. (1984) (0)
Issue Highlights (2021) (0)
Correction: Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration (2009) (0)
iTorin 1 — An Active Site Inhibitor of mTOR , Suppresses Prostate Cancer Cell Growth Induced by Activated α 2 M-Macroglobulin Ligation of Cell Surface GRP 78 (2013) (0)
Abstract 3698: Inhibition of cholesterol uptake with ezetimibe reduces intra-tumoral testosterone levels and slows tumor growth in transgenic mouse models of prostate cancer. (2013) (0)
ing therapy, e.g., in the caseof t-PA (2). Patients who shouldnot be given streptokinase or anistreplasecould be identifiedbeforehand,as couldpatientswho require higher doses to overcome neutralizing antibodies. (1993) (0)
from Patient Serum Antibodies against Glucose-Regulated Protein 78 Isolated Is Modulated by In vitro Prostate Cancer Cell Proliferation (2006) (0)
Kallikrein in the Interstitial Space (2016) (0)
Serine Proteinases and Their Inhibitors (2012) (0)
103A: ANGIOTENSIN TYPE 1 RECEPTOR BLOCKERS INHIBIT MYOSIN II-DEPENDENT MIGRATION IN KELOID FIBROBLASTS (2010) (0)
Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model (2012) (0)
Profiling Plasma Caspase Activity in Heart Failure and During LVAD support as Biomarkers of Cardiac Health and Recovery Presenter : (2017) (0)
in Mice -Interferon γ Clearance and Distribution of Recombinant Murine (2013) (0)
Cadmium-induced mitogenesis in macrophages is dependent on the generation of inositol (1,4,5)-trisphosphate (2000) (0)
Abstract 1247: Development of GRP78 scFv-Subtilase fusion proteins for sensitization of melanoma to chemotherapeutics. (2013) (0)
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages. (2023) (0)
Lipoprotein (a) promotes plasmin inhibition by a2-antiplasmin (2005) (0)
Low Is “Low Enough”? (2010) (0)
Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer (2018) (0)
Oral contraceptives and thromboembolic disease. (1986) (0)
Mechanism of proteinase inhibition in inter alpha trypsin inhibitor (1986) (0)
Effect of Hyperoxia on Central Nervous System Intercellular Communication Mediated by Tunneling Nanotubes (2015) (0)
The laboratory of Judah Folkman identified the potent endogenous antiangiogenic protein angiostatin in 1994 (2009) (0)
Molecular abnormalities of human plasminogen isolated from synovial fluid of rheumatoid arthritis patients. (1997) (0)
Abstract 3220: The effects of cholesterol treatment drugs alone and in combination on prostate tumor xenograft growth (2012) (0)
ELIMINATION OF DIETARY CARBOHYDRATE EXTENDS SURVIVAL OF MICE BEARING LNCAP XENOGRAFTS (2008) (0)
Interaction Between Heat Shock Proteins and Components of the Plasminogen Activator System in the Central Nervous System (2019) (0)
1435 THE USE OF SIMVASTATIN AND EZETIMIBE AS NOVEL THERAPEUTICS FOR PROSTATE CANCER IN A XENOGRAFT MODEL (2010) (0)
Fibrinolytic Defects in the Cutaneous Vasculitis Atrophie Blanche (2019) (0)
Serum Pro-N-Cadherin Is a Marker of Subclinical Heart Failure in the General Population. (2023) (0)
Effect of interferon-gamma and human alpha 2-macroglobulin on peritoneal macrophage morphology and Ia antigen expression. (1990) (0)
The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen. (41.12) (2007) (0)
and Peptide Cross-Presentation (Glycoprotein 96) Surface Binding, Uptake, Re-Examination of CD91 Function in GRP94 (2010) (0)
Modulation of peritoneal macrophage mp membrane antigens by alpha 2 macroglobulin trypsin a 2m t complexes (1987) (0)
Prostate CancerXenografts in aCell-Line SpecificManner , ThroughParadoxical Effects onOncogenic Pathways (2013) (0)
1436 SIMVASTATIN INHIBITS THE GROWTH OF ANDROGEN-SENSITIVE AND ANDROGEN-INDEPENDENT CELLS IN VITRO (2010) (0)
24 IMMUNOCHEMICAL AND BIOCHEMICAL ANALYSIS OF THE HUMAN GLIOMA EXTRACELLULAR MATRIX GLYCOPROTEIN (GMEM) (1984) (0)
Stores in Peritoneal Macrophages and Release of Calcium from Intracellular 1,4,5-Trisphosphate Binding to Its Receptors Cyclosporin A Inhibits Inositol (1998) (0)
Novel Cell Surface Targets for the Plasminogen Activating System in the Brain (2018) (0)
Lipoprotein Receptor Signaling (2003) (0)
Matrix Metalloproteinases in the Interstitial Space (2016) (0)
FACTOR VIII-A MARKER OF ENDOTHELIAL CELLS IN NORMAL BRAIN AND GLIOMAS: 71 (1979) (0)
Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains. (2017) (0)
EVALUATION OF PULMONARY ARTERIAL OCCLUSION FOLLOWING TRANSCATHETER ELECTROCOAGULA-TION (TCEC) BY CT (1980) (0)
61 – PLASMINOGEN ACTIVATORS BY USE OF 3H-LABELED CASEIN SUBSTRATE (1981) (0)
Composition and Function of the Interstitial Fluid (2016) (0)
Purification and characterization of human alpha 2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography. (1986) (0)
RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH (2009) (0)
Signaling 2 a Translocation of GRP78, a Receptor for The Role of MTJ-1 in Cell Surface (2005) (0)

This paper list is powered by the following services:

Other Resources About Salvatore Pizzo

en.wikipedia.org

What Schools Are Affiliated With Salvatore Pizzo?

Salvatore Pizzo is affiliated with the following schools:

Salvatore Pizzo's Academic­Influence.com Rankings

Salvatore Pizzo's Degrees

Why Is Salvatore Pizzo Influential?

Salvatore Pizzo's Published Works

Published Works

Other Resources About Salvatore Pizzo

What Schools Are Affiliated With Salvatore Pizzo?

Salvatore Pizzo's AcademicInfluence.com Rankings